We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FOX:NASDAQFox Corporation Analysis

Data as of 2026-03-13 - not real-time

$52.03

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Fox Corp. is trading at $52.03, just below its 20‑day SMA of 52.23 and well under its 50‑day SMA of 59.13, indicating short‑term price weakness but a potential rebound. The RSI of 37 suggests the stock is approaching oversold territory, while the MACD line sits above its signal line, producing a modest positive histogram that points to emerging bullish momentum. Support sits at 48.76 and resistance at 54.48, giving the price a relatively tight range. Volatility remains high at roughly 38% over the past 30 days, yet beta is sub‑1 (0.8), implying the stock moves less than the market overall.
Fundamentally, Fox trades at a trailing P/E of 12.5, well below the industry average of 17.8, and a forward P/E of 10.5, signaling value relative to peers. The dividend yield of 1.07% is supported by a low payout ratio of 13% and strong operating cash flow, making the payout sustainable. However, the DCF‑derived fair value of $44.30 is materially lower than the current price, flagging a valuation gap. Recent news adds nuance: Seaport Global upgraded its outlook to Buy, while Bank of America downgraded to Underperform and cut its target to $45, reflecting divergent analyst sentiment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram despite neutral trend
  • RSI near oversold levels
  • Proximity to strong support at $48.76

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Seaport Global upgrade to Buy
  • P/E well below industry average
  • Sustainable dividend and strong cash flow

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • DCF fair value suggests price overextension
  • Modest revenue growth of 2%
  • Potential regulatory and sector cyclicality risks

Key Metrics & Analysis

Financial Health

Revenue Growth2.00%
Profit Margin11.41%
P/E Ratio12.5
ROE16.82%
ROA8.81%
Debt/Equity67.39
P/B Ratio2.0
Op. Cash Flow$2.7B
Free Cash Flow$1.8B
Industry P/E17.8

Technical Analysis

TrendNeutral
RSI37.4
Support$48.76
Resistance$54.48
MA 20$52.23
MA 50$59.13
MA 200$55.84
MACDBullish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair Value$44.30
GradeFair
TypeValue
Dividend Yield1.07%

Risk Assessment

Beta0.82
Volatility37.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.